ABT – abbott laboratories (US:NYSE)

Diabetes Products To Drive Abbott's Q3 [Forbes]

Gastrointestinal Diseases Therapeutics Market to Grow by USD 18.5 Billion from 2024-2028 Driven by Rising Disease Incidence, with AI Shaping Market Trends - Technavio [Yahoo! Finance]

Embolization Coil Market to Grow by USD 538.3 Million from 2024-2028 Driven by Rising Incidence of Aneurysms, Report on AI-Driven Market Transformation - Technavio [Yahoo! Finance]

Pharmacogenomics Industry Report 2024: Analysis by Technology, Application, End-user, Region, and Company with Growth Forecasts to 2032 [Yahoo! Finance]

Abbott Laboratories' (NYSE:ABT) five-year earnings growth trails the respectable shareholder returns [Yahoo! Finance]

Cardiac Surgeons at Pittsburgh's Allegheny General Hospital First in the State to Successfully Implant New Device to Repair Leaky Tricuspid Heart Valve

What if you could choose how to use your 401(k) match? One company's trying that. [USA TODAY]

Abbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac Mapping

Peripheral Vascular Devices Market Forecast Report 2024: Technological Advancements, Increasing Prevalence of Vascular Diseases, Growing Awareness and Diagnosis Fueling the $18.47 Billion Industry [Yahoo! Finance]

Abbott (ABT) Earnings Expected to Grow: Should You Buy? [Yahoo! Finance]

Blood Screening Market Growth at USD 6.33 Billion by 2031 | SkyQuest Technology [Yahoo! Finance]

Germany Pharmaceuticals Market Report 2024-2028: Consolidation through Mergers and Acquisitions Catalyzing Growth [Yahoo! Finance]

Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Royal Bank of Canada from $125.00 to $130.00. They now have an "outperform" rating on the stock.

Abbott started at outperform by Oppenheimer, diversified portfolio cited [Seeking Alpha]

Abbott Laboratories (NYSE: ABT) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $130.00 price target on the stock.

Pregnancy Detection Kits Industry Report 2024, Featuring Key Players Alere, Church & Dwight, Confirm BioSciences, CVS Health, Mankind Pharma, Philippine Blue Cross Biotech, Prestige Brands and Quidel [Yahoo! Finance]

Guidewires Market to grow by USD 807 Million from 2024-2028, driven by rising chronic disorders, AI-powered report highlights impact on market trends - Technavio [Yahoo! Finance]

Global Drug Device Combination Products Market is expected to reach revenue of USD 389.7 Bn by 2033, at 9.3% CAGR: Dimension Market Research. [Yahoo! Finance]

Organic Baby Formula Market to Reach $17.7 Billion, Globally, by 2033 at 9.5% CAGR: Allied Market Research [Yahoo! Finance]

Jim Cramer says Abbott Labs picked up a ‘very big win' — here's where the stock is going [CNBC]

Cramer's Stop Trading: Abbott Labs [CNBC]

Abbott Laboratories (NYSE:ABT) is favoured by institutional owners who hold 77% of the company [Yahoo! Finance]

3 Magnificent Dividend Stocks to Buy in October [Yahoo! Finance]

2 Top Dividend Stocks Yielding 3% or More to Buy Without Hesitation Right Now [Yahoo! Finance]

WHO approves Abbott's mpox test for emergency use [Yahoo! Finance]